BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 15493113)

  • 1. [Serum uric acid--a cardiovasular risk factor?].
    Alderman M; Redfern JS
    Ther Umsch; 2004 Sep; 61(9):547-52. PubMed ID: 15493113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uric acid: role in cardiovascular disease and effects of losartan.
    Alderman M; Aiyer KJ
    Curr Med Res Opin; 2004 Mar; 20(3):369-79. PubMed ID: 15025846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Uric acid--more deleterious than we thought?].
    Høieggen A; Os I; Kjeldsen SE
    Tidsskr Nor Laegeforen; 2005 May; 125(10):1330-2. PubMed ID: 15909004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials of uric acid lowering for coronary heart disease risk reduction.
    Simon JA
    Am J Med; 2006 Apr; 119(4):e5; author reply e7. PubMed ID: 16564763
    [No Abstract]   [Full Text] [Related]  

  • 5. To study the efficacy of Losartan on urinary uric acid excretion in Thiazide induced hyperuricemic and hypertensive patients.
    Khan M; Khan RA; Islam F; Laghari J; Jamali SN
    Pak J Pharm Sci; 2011 Oct; 24(4):583-7. PubMed ID: 21959825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid and oxidative stress: relative impact on cardiovascular risk?
    Strazzullo P; Puig JG
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):409-14. PubMed ID: 17643880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study.
    Chen JH; Chuang SY; Chen HJ; Yeh WT; Pan WH
    Arthritis Rheum; 2009 Feb; 61(2):225-32. PubMed ID: 19177541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular-specific effects of angiotensin II antagonists: clinical relevance to treating hypertension?
    Reid JL
    J Renin Angiotensin Aldosterone Syst; 2005 Mar; 6(1):15-24. PubMed ID: 16088847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Uric acid, cardiovascular events and renal dysfunction: a circumstantial connection?].
    Petriş A; Cimpoeşu D; Petriş O; Costache I
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):407-12. PubMed ID: 23077928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum uric acid and the risk of hypertension and chronic kidney disease.
    Feig DI
    Curr Opin Rheumatol; 2014 Mar; 26(2):176-85. PubMed ID: 24419747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of losartan versus candesartan on uric acid, renal function, and fibrinogen in patients with hypertension and hyperuricemia associated with diuretics.
    Rayner BL; Trinder YA; Baines D; Isaacs S; Opie LH
    Am J Hypertens; 2006 Feb; 19(2):208-13. PubMed ID: 16448895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived.
    Viazzi F; Leoncini G; Ratto E; Pontremoli R
    J Clin Hypertens (Greenwich); 2006 Jul; 8(7):510-8. PubMed ID: 16849905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lozartan potential in hyperuricemia correction].
    Ter Arkh; 2011; 83(10):45-8. PubMed ID: 22185025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum uric acid: a risk factor and a target for treatment?
    Feig DI; Mazzali M; Kang DH; Nakagawa T; Price K; Kannelis J; Johnson RJ
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S69-73. PubMed ID: 16565251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium antagonists: current and future applications based on new evidence. The mechanisms on lowering serum uric acid level by calcium channel blockers].
    Mizuta E; Hamada T; Igawa O; Shigemasa C; Hisatome I
    Clin Calcium; 2010 Jan; 20(1):45-50. PubMed ID: 20048433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status of uric acid management in hypertensive subjects.
    Yamamoto Y; Matsubara K; Igawa G; Kaetsu Y; Sugihara S; Matsuura T; Ando F; Sonoyama K; Hamada T; Ogino K; Igawa O; Shigemasa C; Hisatome I
    Hypertens Res; 2007 Jun; 30(6):549-54. PubMed ID: 17664859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is hyperuricemia a cardiovascular risk factor?].
    Chizyński K; Rózycka M
    Wiad Lek; 2006; 59(5-6):364-7. PubMed ID: 17017483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperuricemia and cardiovascular disease risk.
    Borghi C; Verardi FM; Pareo I; Bentivenga C; Cicero AF
    Expert Rev Cardiovasc Ther; 2014 Oct; 12(10):1219-25. PubMed ID: 25192804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperuricemia in hypertension: any clinical implication?].
    Deléaval P; Burnier M
    Rev Med Suisse; 2005 Sep; 1(32):2072-4, 2077-9. PubMed ID: 16238227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.